AlphaYouNA
Insider selling
Noubar Afeyan sold $434K of Moderna, Inc. (MRNA) stock
Noubar Afeyan, Dir of Moderna, Inc. (MRNA), sold 9,263 shares of MRNA stock worth $434K, per an SEC Form 4 filed May 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 21, 2026, 1 day before it was made public.
MRNA has moved +265.9% since the trade date, from $47.26 to $172.94 (Sep 21, 2026 close).
- Traded
- May 21, 2026
- Disclosed
- May 22, 2026
- Filing delay
- 1 day
- Price since
- +265.9%
- Role
- Dir
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.